United States · FDA National Drug Code directory
Brimonidine Tartrate/Timolol Maleate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-281_e97c8703-5166-49b6-8dd2-69c5b9dfcae8
- Product NDC
- 68462-281
- Form
- SOLUTION/ DROPS
- Composition / generic term
- Brimonidine Tartrate and Timolol Maleate
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240516
- Source listing expiry
- 20271231
Source-listed ingredients
- BRIMONIDINE TARTRATE — 2 mg/mL
- TIMOLOL MALEATE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (68462-281-32) / 10 mL in 1 BOTTLE, DROPPER · 68462-281-32
- 1 BOTTLE, DROPPER in 1 CARTON (68462-281-69) / 5 mL in 1 BOTTLE, DROPPER · 68462-281-69
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →